| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| para-Hydroxyamphetamine measurement (procedure) |
Component |
True |
Hydroxyamfetamine (substance) |
Inferred relationship |
Some |
1 |
| Hydroxyamfetamine hydrobromide (substance) |
Is a |
False |
Hydroxyamfetamine (substance) |
Inferred relationship |
Some |
|
| Product containing hydroxyamfetamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydroxyamfetamine (substance) |
Inferred relationship |
Some |
1 |
| Hydroxyamfetamine hydrobromide (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Hydroxyamfetamine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely hydroxyamfetamine hydrobromide 10 milligram/1 milliliter and tropicamide 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydroxyamfetamine (substance) |
Inferred relationship |
Some |
|
| Product containing hydroxyamfetamine and tropicamide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydroxyamfetamine (substance) |
Inferred relationship |
Some |
1 |
| Hydroxyamfetamine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydroxyamfetamine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only hydroxyamfetamine and tropicamide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydroxyamfetamine (substance) |
Inferred relationship |
Some |
1 |
| Hydroxyamfetamine and tropicamide only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydroxyamfetamine (substance) |
Inferred relationship |
Some |
1 |
| Hydroxyamfetamine- and tropicamide-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydroxyamfetamine (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]